Evidence map›Paper›PMID 27025763›Full record

ArticleAge and ageing2016

Geographic variation of inpatient care costs at the end of life.

Claudia Geue, Olivia Wu, Alastair Leyland, Jim Lewsey, Terry J Quinn

Abstract readComparative Study
In one paragraph

Article in Age and ageing, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province, China.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Claudia GeueHealth Economics and Health Technology Assessment, University of Glasgow, Glasgow G12 8RZ, United Kingdom of Great Britain and Northern Ireland.
Olivia WuHealth Economics and Health Technology Assessment, University of Glasgow, Glasgow G12 8RZ, United Kingdom of Great Britain and Northern Ireland.
Alastair LeylandMRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland.
Jim LewseyHealth Economics and Health Technology Assessment, University of Glasgow, Glasgow G12 8RZ, United Kingdom of Great Britain and Northern Ireland.
Terry J QuinnInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom of Great Britain and Northern Ireland.

Funding

Chief Scientist Office PDF/13/03Medical Research Council MC_UU_12017/13
6 · The paper itself

Abstract

backgroundcosts incurred at the end of life are a main contributor to healthcare expenditure. Urban-rural inequalities in health outcomes have been demonstrated. Issues around geographical patterning of the association between time-to-death and expenditure remain under-researched. It is unknown whether differences in outcomes translate into differences in costs at the end of life.

methodswe used a large representative sample of the Scottish population obtained from death records linked to acute inpatient care episodes. We performed retrospective analyses of costs and recorded the most frequent reasons for the last hospital admission. Using a two-part model, we estimated the probability of healthcare utilisation and costs for those patients who incurred positive costs.

resultseffects of geography on costs were similar across diagnoses. We did not observe a clear gradient for costs, which were lower in other urban areas compared with large urban areas. Patients from remote and very remote areas incurred higher costs than patients from large, urban areas. The main driver of increased costs was increased length of stay.

conclusionsour results provide evidence of additional costs associated with remote locations. If length of stay and costs are to be reduced, alternative care provision is required in rural areas. Lower costs in other urban areas compared with large urban areas may be due to urban centres incurring higher costs through case-mix and clinical practice. If inequalities are driven by hospital admission, for an end of life scenario, care delivered closer to home or home-based care seems intuitively attractive and potentially cost-saving.

Indexed as

Hospital CostsCohort StudiesCost-Benefit AnalysisCritical IllnessDatabases, FactualFemaleHealthcare DisparitiesHealth ExpendituresHospitalizationHumansInpatientsLongitudinal StudiesMaleRetrospective StudiesRisk AssessmentRural Populationend of lifegeographyhealthcare expenditureolder people

Identifiers

PMID27025763
PMCPMC4846794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.